CJC 1295 DAC vs Tesamorelin
Evidence tier, human-evidence strength, regulatory status, and hype-vs-data — side by side.
On published evidence, Tesamorelin currently grades higher (A-tier vs F-tier). That reflects evidence maturity, not that it's “better” for any person or goal.
- Stronger human evidence: Tesamorelin
- More hype than data: neither stands out
| cjc-1295-dac | tesamorelin | |
|---|---|---|
| Class | Growth-hormone secretagogues | Growth-hormone secretagogues |
| Regulatory status | Research-use-only | FDA-approved |
| Candidate sources | 0 | 0 |
| Top study types (candidate) | — | — |
| Translation risk | pending review | pending review |
CJC 1295 DAC vs Tesamorelin: FAQ
Is CJC 1295 DAC better than Tesamorelin?
On published evidence, Tesamorelin currently grades higher (A-tier vs F-tier). That reflects evidence maturity, not that it's “better” for any person or goal. Neither is a recommendation to use anything; this compares the state of the evidence only.
What's the difference between CJC 1295 DAC and Tesamorelin?
CJC 1295 DAC is research-use-only and sits at the “Mechanism” evidence stage; Tesamorelin is FDA-approved for a specific indication and sits at “Approved use.”
Which has stronger human evidence, CJC 1295 DAC or Tesamorelin?
Tesamorelin has the stronger human-evidence signal of the two on our scale.
Research reference only. Not medical advice, treatment instructions, or a purchase recommendation. Consult a licensed professional.